Access cutting-edge atopic dermatitis treatment through this clinical trial at a research site in Phoenix. Study-provided care at no cost to qualified participants.
Access atopic dermatitis specialists in Phoenix at no cost
This study follows strict safety protocols and ethical guidelines
All study-related atopic dermatitis treatment provided free
This is a single group, 1-arm, long-term safety study for treatment of participants with moderate to severe atopic dermatitis (AD). The purpose of this study is to characterize the long-term safety and efficacy of amlitelimab in treated participants with age ≥12 years old with moderate to severe AD. The study duration per participant will be up to 284 weeks, including: * A screening period of up to 2 to 4 weeks * An open label treatment period of up to 268 weeks (approximately 5 years) * A po
Sponsor: Sanofi
Check if you qualify for this atopic dermatitis clinical trial in Phoenix, AZ
If you're searching for atopic dermatitis treatment options in Phoenix, AZ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Phoenix research site is actively enrolling participants for this clinical trial. You'll receive care from experienced atopic dermatitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.